James R. Meyers - Jun 11, 2025 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
Director
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for James R. Meyers
Stock symbol
CTMX
Transactions as of
Jun 11, 2025
Transactions value $
$0
Form type
4
Date filed
6/13/2025, 04:17 PM
Previous filing
Jun 6, 2024
Next filing
Jun 16, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Meyers James R Director C/O CYTOMX THERAPEUTICS, INC., 151 OYSTER POINT BLVD., STE. 400, SOUTH SAN FRANCISCO /s/ Lloyd Rowland, as Attorney-in-Fact for James R. Meyers 2025-06-13 0001387521

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTMX Stock Option (Right to Buy) Award $0 +38K $0.00 38K Jun 11, 2025 Common Stock 38K $2.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2026 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.